欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

金属化DNA寡核苷酸适配子对于前列腺癌的治疗

Metallated DNA Aptamers For Prostate Cancer Treatment

作者:Gmeiner, W. 加工时间:2015-07-30 信息来源:科技报告(AD) 索取原文[40 页]
关键词:脱氧核糖核酸;体内分析;前列腺癌;锌细胞;医药
摘 要:The purpose of this project is to develop aptamer-targeted DNA:Zn2+ complexes that are highly efficacious for prostate cancer treatment. Significant progress has been made on refining novel Zn2+-binding DNA motifs that utilize FdU nucleotides and that are highly cytotoxic towards prostate cancer cells. We demonstrated netropsin binding to the 3 -FdU DNA hairpin, clarified the mode of Zn2+ binding to this complex and demonstrated the Zn2+/DNA/netropsin ternary complex is highly cytotoxic towards prostate cancer cells. We also demonstrated DNA hairpins with stems consisting of G-FdU base pairs form complexes with Zn2+ that have increased stability at physiological pH relative to stems consisting of A-FdU base pairs. We completed SELEX and identified a new DNA aptamer to PSMA and demonstrated selective binding towards PSMA+ prostate cancer cells. We demonstrated that Zn2+-pyrithione is synergistic with FdUMP 10 for inducing cytotoxicity towards prostate cancer cells. We have purchased animals and are ready to evaluate Zn2+- pyrithione/FdUMP 10 in vivo in the coming months. All components are in place for forming the dimeric aptamer complexes and evaluating cytotoxicity in vitro and in vivo.
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服